Quantum Capital Management acquired a new position in Sientra, Inc. (NASDAQ:SIEN) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 86,470 shares of the medical instruments supplier’s stock, valued at approximately $1,332,000. Quantum Capital Management owned approximately 0.45% of Sientra as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. acquired a new stake in Sientra in the 2nd quarter worth about $101,000. Nationwide Fund Advisors raised its stake in Sientra by 260.4% in the 2nd quarter. Nationwide Fund Advisors now owns 10,963 shares of the medical instruments supplier’s stock worth $107,000 after purchasing an additional 7,921 shares in the last quarter. Wells Fargo & Company MN raised its stake in Sientra by 0.3% in the 1st quarter. Wells Fargo & Company MN now owns 12,871 shares of the medical instruments supplier’s stock worth $108,000 after purchasing an additional 40 shares in the last quarter. Accredited Investors Inc. acquired a new stake in Sientra in the 2nd quarter worth about $115,000. Finally, Parametric Portfolio Associates LLC raised its stake in Sientra by 14.4% in the 1st quarter. Parametric Portfolio Associates LLC now owns 16,410 shares of the medical instruments supplier’s stock worth $138,000 after purchasing an additional 2,065 shares in the last quarter. Institutional investors and hedge funds own 76.99% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was first published by Daily Political and is the sole property of of Daily Political. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/11/17/quantum-capital-management-takes-position-in-sientra-inc-sien.html.

Shares of Sientra, Inc. (NASDAQ:SIEN) traded up $0.50 during trading hours on Friday, hitting $14.03. 146,100 shares of the stock traded hands, compared to its average volume of 155,932. The company has a quick ratio of 1.92, a current ratio of 2.87 and a debt-to-equity ratio of 0.57. Sientra, Inc. has a one year low of $7.20 and a one year high of $16.68.

Sientra (NASDAQ:SIEN) last issued its earnings results on Tuesday, November 7th. The medical instruments supplier reported ($0.74) EPS for the quarter, missing the consensus estimate of ($0.68) by ($0.06). The firm had revenue of $9.80 million during the quarter, compared to analyst estimates of $10.54 million. Sientra had a negative net margin of 169.77% and a negative return on equity of 68.82%. Sientra’s quarterly revenue was up 50.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.55) earnings per share. research analysts expect that Sientra, Inc. will post -3.14 EPS for the current year.

Several brokerages have recently commented on SIEN. Canaccord Genuity began coverage on shares of Sientra in a research report on Monday, August 28th. They issued a “buy” rating and a $14.00 target price for the company. Lake Street Capital restated a “buy” rating and issued a $15.00 target price (up from $11.00) on shares of Sientra in a research report on Wednesday, August 2nd. Stifel Nicolaus restated a “hold” rating and issued a $14.00 target price (up from $11.00) on shares of Sientra in a research report on Wednesday, September 27th. William Blair upgraded shares of Sientra from a “market perform” rating to an “outperform” rating in a research report on Wednesday, September 13th. Finally, Zacks Investment Research cut shares of Sientra from a “hold” rating to a “sell” rating in a research report on Tuesday, August 15th. One research analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $13.75.

Sientra Profile

Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.

Institutional Ownership by Quarter for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra Inc. and related companies with MarketBeat.com's FREE daily email newsletter.